High mobility group nucleosomal binding domain 2 pseudogene 40 (HMGN2P40)

HMGN2P40 is a processed pseudogene in the human genome related to the high mobility group nucleosomal binding domain 2 (HMGN2) gene family. Pseudogenes such as HMGN2P40 arise from retrotransposed mRNA copies of their parental coding genes, losing their protein-coding capacity through mutations. While some pseudogenes have regulatory functions at the RNA level, there are no specific reports of HMGN2P40 having a biologically relevant or disease-related role. It is not a therapeutic target, does not encode a protein, and is not used clinically as a biomarker or drug target[3][5][7]. Relevant information may be expanded if future research clarifies a regulatory or pathological function, as is the case for some other pseudogenes in disease processes[1][2]. However, current databases uniformly identify HMGN2P40 as a typical processed pseudogene with no known functional or clinical relevance.